Microstructural white-matter abnormalities associated with treatment resistance, severity and duration of illness in

J de Diego-Adeliño1, P Pires2, B Gómez-Ansón2

  • 1Department of Psychiatry - Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.

Psychological Medicine
|August 22, 2013
PubMed
Abstract

Insights

Treatment-resistant major depressive disorder (MDD) shows widespread white-matter microstructure disruptions, particularly in fronto-limbic networks. These white-matter changes correlate with illness duration and depression severity, indicating a link to treatment resistance.

Area of Science:

  • Neuroimaging
  • Neuropsychiatry
  • Brain Imaging

Background:

  • White-matter abnormalities are reported in major depressive disorder (MDD).
  • Limited data exist on treatment-resistant MDD (TRD) and its clinical burden variables.
  • Understanding white-matter changes in TRD is crucial for treatment strategies.

Purpose of the Study:

  • To examine white-matter microstructure in patients with MDD across different stages.
  • To investigate the relationship between white-matter integrity and treatment resistance in MDD.
  • To identify clinical variables influencing white-matter microstructure in MDD.

Main Methods:

  • Diffusion tensor imaging (DTI) and tract-based spatial statistics (TBSS) were used.
  • 52 patients with MDD (TRD, remitted-recurrent, first-episode) and 17 healthy controls were studied.
  • Results were corrected for familywise error (FWE) rate, and medication effects were controlled.

Main Results:

  • Significant reductions in fractional anisotropy (FA) were observed in TRD patients compared to first-episode MDD and controls.
  • Decreased FA was noted in the ventromedial prefrontal region in TRD compared to remitted-recurrent MDD.
  • Longer illness duration and higher depression severity predicted lower FA in TRD patients.

Conclusions:

  • Disruptions in white-matter microstructure, especially in fronto-limbic networks, are linked to treatment resistance in MDD.
  • These findings highlight the role of white-matter integrity in the clinical burden of depression.
  • The study supports the association between white-matter abnormalities and TRD.

Related Concept Videos

Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...